Labuschagne Naidoo, R.-B.; Steel, H.C.; Theron, A.J.; Anderson, R.; Tintinger, G.R.; Rossouw, T.M.
Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy. Pathogens 2024, 13, 540.
https://doi.org/10.3390/pathogens13070540
AMA Style
Labuschagne Naidoo R-B, Steel HC, Theron AJ, Anderson R, Tintinger GR, Rossouw TM.
Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy. Pathogens. 2024; 13(7):540.
https://doi.org/10.3390/pathogens13070540
Chicago/Turabian Style
Labuschagne Naidoo, Robyn-Brooke, Helen C. Steel, Annette J. Theron, Ronald Anderson, Gregory R. Tintinger, and Theresa M. Rossouw.
2024. "Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy" Pathogens 13, no. 7: 540.
https://doi.org/10.3390/pathogens13070540
APA Style
Labuschagne Naidoo, R.-B., Steel, H. C., Theron, A. J., Anderson, R., Tintinger, G. R., & Rossouw, T. M.
(2024). Persistently Elevated Expression of Systemic, Soluble Co-Inhibitory Immune Checkpoint Molecules in People Living with HIV before and One Year after Antiretroviral Therapy. Pathogens, 13(7), 540.
https://doi.org/10.3390/pathogens13070540